Literature DB >> 19635740

Malignant peritoneal mesothelioma: a multicenter study on 81 cases.

V de Pangher Manzini1, L Recchia, M Cafferata, C Porta, S Siena, L Giannetta, F Morelli, F Oniga, A Bearz, V Torri, M Cinquini.   

Abstract

BACKGROUND: Malignant peritoneal mesothelioma (MPM) is a rare disease characterized by a difficult diagnosis, different types of presentation, variable course and poor prognosis.
MATERIALS AND METHODS: Eighty-one patients with MPM observed in 14 Italian oncology institutions from 1982 to 2007 have been examined with the aim of delineating the history of MPM.
RESULTS: Presentation symptoms were ascites, abdominal pain, asthenia, weight loss, anorexia, abdominal mass, fever, diarrhea and vomiting in various associations. Computed tomography scan and echotomography signs were ascites, abdominal mass and peritoneal thickening. Peritoneal fluid cytology (61 cases) was positive for mesothelioma in 31 and for malignancy, not mesothelioma, in 13. Laparoscopy was carried out in 40 cases and laparotomy in 36. Thrombocytosis was present in 59 cases. Associated tumors diagnosed during the lifetime were colorectal cancer in two cases and cheek carcinoma, thyroid carcinoma, tongue carcinoma, bladder carcinoma and testicular seminoma. Thirty patients were treated with surgery and 45 with chemotherapy. The median survival time from diagnosis is 13 months. Ascites, fever and vomiting were significative variables at presentation; only vomiting holds significance in a multivariate analysis.
CONCLUSIONS: MPM is a disease with various types of presentation, frequently associated with thrombocytosis, sometimes with other tumors. Survival and diagnosis time can differ in various types of MPM. Prognosis is poor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635740     DOI: 10.1093/annonc/mdp307

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  26 in total

Review 1.  Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review.

Authors:  Alfonso García-Fadrique; Akash Mehta; Faheez Mohamed; Sanjeev Dayal; Tom Cecil; Brendan J Moran
Journal:  J Gastrointest Oncol       Date:  2017-10

Review 2.  Malignant peritoneal mesothelioma: a review.

Authors:  Joseph Kim; Shanel Bhagwandin; Daniel M Labow
Journal:  Ann Transl Med       Date:  2017-06

3.  A Rare Complication of Diffuse Malignant Peritoneal Mesothelioma: Spontaneous Ileal Perforation.

Authors:  Orhan Kalaycı; Güven Barış Cansu; Bengür Taşkıran; Özlem Eren
Journal:  Indian J Surg Oncol       Date:  2019-04-06

Review 4.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

Review 5.  Advances in malignant peritoneal mesothelioma.

Authors:  Shoubo Cao; Shi Jin; Jingyan Cao; Jing Shen; Jing Hu; Dehai Che; Bo Pan; Jiawen Zhang; Xiaoxi He; Dian Ding; Feifei Gu; Yan Yu
Journal:  Int J Colorectal Dis       Date:  2014-10-21       Impact factor: 2.571

6.  Predictive factors analysis for malignant peritoneal mesothelioma.

Authors:  Shi Jin; Shoubo Cao; Jingyan Cao; Jing Shen; Jing Hu; Dehai Che; Jiawen Zhang; Yan Yu
Journal:  J Gastrointest Surg       Date:  2014-10-09       Impact factor: 3.452

Review 7.  Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.

Authors:  J Spiliotis; E Halkia; E de Bree
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

Review 8.  Advances in the management of peritoneal mesothelioma.

Authors:  Ali Raza; Wei-Ching Huang; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

9.  Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.

Authors:  Aaron U Blackham; Edward A Levine
Journal:  European J Clin Med Oncol       Date:  2012-07

10.  Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma.

Authors:  Krishna Pillai; Mohammad Hossein Pourgholami; Terence C Chua; David Lawson Morris
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.